AVI BioPharma reports data from AVI-6002, AVI-6003 trials
The Phase I single ascending dose trials were intended to evaluate the safety, tolerability and pharmacokinetics of each therapeutic candidate in healthy adult volunteers. The company is conducting
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.